Compare OLP & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLP | TKNO |
|---|---|---|
| Founded | 1982 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.5M | 482.7M |
| IPO Year | 1995 | 2021 |
| Metric | OLP | TKNO |
|---|---|---|
| Price | $22.34 | $6.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $27.17 | $9.67 |
| AVG Volume (30 Days) | 77.8K | ★ 528.2K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | ★ 8.05% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $82,740,000.00 | $40,520,000.00 |
| Revenue This Year | $11.60 | $13.53 |
| Revenue Next Year | $1.95 | $14.50 |
| P/E Ratio | $22.40 | ★ N/A |
| Revenue Growth | 1.02 | ★ 7.35 |
| 52 Week Low | $19.62 | $1.91 |
| 52 Week High | $25.88 | $9.48 |
| Indicator | OLP | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.01 | 37.13 |
| Support Level | $22.36 | $6.33 |
| Resistance Level | $23.63 | $7.66 |
| Average True Range (ATR) | 0.43 | 0.61 |
| MACD | 0.10 | -0.31 |
| Stochastic Oscillator | 92.52 | 33.20 |
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.